These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9278467)

  • 21. Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1024-5. PubMed ID: 11484301
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins].
    Lobato-Mendizábal E; Majluf-Cruz A
    Rev Invest Clin; 2000; 52(5):529-45. PubMed ID: 11195182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost-effectiveness of low-molecular-weight heparins for deep venous thrombosis.
    Reilly BM; Evans A
    Ann Intern Med; 2000 Mar; 132(6):508-9. PubMed ID: 10733457
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of deep vein thrombosis using low-molecular-weight heparins.
    Groce JB
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LMW heparins: from transition to fruition.
    Check W
    CAP Today; 1999 Jun; 13(6):1, 62, 66-7; passim. PubMed ID: 10539128
    [No Abstract]   [Full Text] [Related]  

  • 27. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparins. A pharmacologic overview.
    Hillis LB
    Adv Nurse Pract; 1997 Oct; 5(10):53-6. PubMed ID: 9459986
    [No Abstract]   [Full Text] [Related]  

  • 29. Is unfractionated heparin equivalent to low-molecular-weight heparin for venous thromboembolism?
    Graber MA; Dachs R; Darby-Stewart A
    Am Fam Physician; 2008 Jun; 77(11):1492-3. PubMed ID: 18581828
    [No Abstract]   [Full Text] [Related]  

  • 30. Low molecular weight heparins: the future of thromboembolic therapy.
    Dobbin KR
    Nurse Pract; 1998 Mar; 23(3):98,101-4,106-7. PubMed ID: 9560832
    [No Abstract]   [Full Text] [Related]  

  • 31. The end of the heparin pump? Low molecular weight heparins have practical advantages, but clinical advantages are small.
    Stein K; Nicholson T
    BMJ; 1999 Aug; 319(7209):576. PubMed ID: 10523087
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of arterial thrombosis with low molecular weight heparins.
    Chesebro JH
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):26-34. PubMed ID: 9399407
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of venous thromboembolism using only low-molecular-weight heparin?
    White RH
    Am J Med; 2001 Aug; 111(2):159-60. PubMed ID: 11498072
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prophylaxis of postoperative thromboembolism. New alternatives to low-molecular-weight heparin].
    Bergqvist D; Siegbahn A
    Lakartidningen; 2002 Jul; 99(28-29):3039-41. PubMed ID: 12170516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
    Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR
    Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight heparins for arterial thrombosis.
    Nenci GG; Minciotti A
    Vasc Med; 2000; 5(4):251-8. PubMed ID: 11213238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of low molecular weight heparin in total knee arthroplasty.
    Iobst CA; Friedman RJ
    Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis.
    Shorr AF; Jackson WL; Weiss BM; Moores LK
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):309-16. PubMed ID: 17473570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.